Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. This approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, the Company is building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs.
TypePublic
HQSouth San Francisco, US
Founded2001
Size (employees)15 (est)-11%
Websitethresholdpharm.com
Threshold Pharmaceuticals was founded in 2001 and is headquartered in South San Francisco, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Threshold Pharmaceuticals

Harold Selick

Harold Selick

CEO
Tillman Pearce

Tillman Pearce

Chief Medical Officer
Show more

Threshold Pharmaceuticals Office Locations

Threshold Pharmaceuticals has an office in South San Francisco
South San Francisco, US (HQ)
300 170 Harbor Way
Show all (1)
Report incorrect company information

Threshold Pharmaceuticals Financials and Metrics

Threshold Pharmaceuticals Revenue

USD

Revenue (Q2, 2018)

1.8m

Net income (Q2, 2018)

18.4m

EBIT (Q2, 2018)

19.1m

Market capitalization (31-Aug-2018)

154.9m

Cash (30-Jun-2018)

41.6m

EV

116.4m
Threshold Pharmaceuticals's current market capitalization is $154.9 m.
Annual
USDFY, 2016

General and administrative expense

7.8m

R&D expense

16.6m

Operating expense total

24.4m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q2, 2018

Revenue

3.7m3.7m3.7m3.7m3.7m3.7m3.7m648.0kwdxefcqufszuzezftuxetqsqxt1.8m

General and administrative expense

2.5m2.4m2.6m2.5m2.4m2.2m1.9m1.7m2.9m4.0m6.6m

R&D expense

8.7m8.9m10.7m10.1m8.1m6.0m4.0m3.5m1.6m2.5m14.4m

Operating expense total

11.1m11.3m13.3m12.6m10.5m8.3m5.9m5.2m4.4m6.5m21.0m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

7.3m8.4m9.6m10.6m

Inventories

2.2m832.0k2.6m623.0k

Current Assets

86.0m66.7m53.2m24.2m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q2, 2018

Cash

6.5m11.2m21.1m10.6m13.7m11.2m12.4m15.2m11.4m68.2m41.6m

Accounts Receivable

38.0k

Inventories

1.4m

Current Assets

70.1m74.1m82.1m72.2m62.2m40.6m35.8m29.5m20.0m69.6m44.2m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(28.4m)(21.6m)43.8m(24.1m)

Depreciation and Amortization

1.5m1.3m1.0m423.0k

Inventories

(1.1m)1.3m(774.0k)2.1m

Accounts Payable

781.0k385.0k(1.3m)97.0k
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2018

Net Income

(766.0k)(7.7m)(11.2m)(8.3m)(6.4m)(7.9m)(6.9m)(5.7m)(5.1m)18.4m

Depreciation and Amortization

187.0k

Accounts Payable

2.9m3.4m1.8m635.0k436.0k1.6m3.1m699.0k328.0k(1.9m)

Cash From Operating Activities

(14.1m)
USDY, 2018

EV/EBIT

6.1 x

EV/CFO

-8.2 x

Financial Leverage

1.3 x
Show all financial metrics
Report incorrect company information

Threshold Pharmaceuticals Company Life and Culture

Report incorrect company information